Multimorbidity and COVID 19: A catastrophic combination

by:Jeemon Panniyammakal Multimorbidity is the existence of multiple long-term mental, physical, and cognitive disorders in one patient. These could include diabetes, hypertension, lung diseases, heart attacks, stroke, kidney failure, mental health conditions, and liver problems or other chronic conditions. Multimorbid conditions often share common disease causes and consequences. The disease pattern, progression and trajectories inContinue reading “Multimorbidity and COVID 19: A catastrophic combination”

Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension

byLucrecia M. Burgos Angiotensin-converting enzyme inhibitors (ACEI) and angiotensin receptor blockers (ARB) are not associated with severity and outcomes of coronavirus disease 2019 (COVID-19) infection in hospitalized patients with hypertension  in Wuhan, China according to a recent study in JAMA Cardiology1. In this retrospective single-centre analysis, the authors analysed hospitalized patients with COVID-19 at the Central HospitalContinue reading “Association of renin-angiotensin system inhibitors with severity and outcomes of COVID-19 infection in hospitalized patients with hypertension”

Impact of the COVID-19 pandemic on interventional cardiology activity

by:Lucrecia Maria Burgos An important reduction in the activity in interventional cardiology has been observed during the COVID-19 epidemic according to a recent study in REC Interventional Cardiology1. The authors carried out a survey in 81 centres involved in ST-elevation myocardial infarction (STEMI) networks in the 17 autonomous communities of Spain. Information was collected on diagnosticContinue reading “Impact of the COVID-19 pandemic on interventional cardiology activity”

The Implications of Viral Particles in the Myocardium

by.Darryl Leong Systolic left ventricular dysfunction in the absence of obstructive coronary artery disease has been described in several anecdotes and case reports in patients with COVID-19. The mechanisms underlying the cardiomyopathy is unclear. In a case report, Tavazzi, et al. describe the first instance of coronavirus-like particles seen by electron microscopy in the myocardiumContinue reading “The Implications of Viral Particles in the Myocardium”

Cardiac Biomarkers and COVID19

by:Darryl Leong In a single-centre retrospective study of 273 patients from Wuhan, China, Han et al. reported that 10% had elevated troponin I and 12% had elevated NT-proBNP concentrations(1). Elevated cardiac biomarker levels were more common among severely ill patients as compared to milder cases. Among mild cases, 5% and 7% had elevated troponin IContinue reading “Cardiac Biomarkers and COVID19”

Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19)

by:Lucrecia M. Burgos Myocardial injury is significantly associated with fatal outcome of COVID-19, while the prognosis of patients with underlying (CVD) but without myocardial injury is relatively favourable according to a recent study in JAMA Cardiology1. In this retrospective single-centre case series, the authors analysed consecutive hospitalized patients with COVID-19 at the Seventh Hospital of WuhanContinue reading “Cardiovascular implications of fatal outcomes of patients with Coronavirus disease 2019 (COVID-19)”

The link between smoking and COVID 19; should we wait for more evidence to quit smoking?

by: Jeemon Panniyammakal Various international agencies such as the World Health Organisation, and Centre for Disease Control and Prevention consider tobacco use as a risk condition associated with susceptibility to COVID 19 and progression to adverse outcomes. Vardavas and Nikitara conducted a systematic review of evidence to evaluate the association between smoking and COVID 19Continue reading “The link between smoking and COVID 19; should we wait for more evidence to quit smoking?”

Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China

by:Lucrecia M. Burgos Patients with previous cardiovascular metabolic diseases may face a greater risk of developing into the severe condition and the comorbidities can also greatly affect the prognosis of the 2019 novel corona virus (2019-nCoV) disease (COVID-19). On the other hand, COVID-19 can, in turn, aggravate the damage to the heart, according to aContinue reading “Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China”

Should cardiovascular disease comorbidity scare you during the COVID-19 season?

by: Dr. Jeemon Panniyammakal, PhD, MPH, FESC The SARS-CoV-2 infection (corona virus infection) spread has reached pandemic proportions. Globally, as on 31 March, 2020 nearly 0.8 million corona virus disease (COVID-19) cases and 38,000 related deaths are reported. Countries around the world are particularly “shielding” or “protecting” individuals with cardiovascular disease (CVD) from external exposureContinue reading “Should cardiovascular disease comorbidity scare you during the COVID-19 season?”

Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies?

by: Darryl Leong The impact of COVID-19 on the delivery of care for emergency cardiovascular illness is unknown. In this report, Tam, et al. describe the timeliness of primary percutaneous coronary intervention for ST elevation myocardial infarction (STEMI) in 7 consecutive patients presenting to a single centre in Hong Kong, China, between January 25, andContinue reading “Can the fear of COVID-19 lead to harmful delays in seeking care for cardiovascular emergencies?”